Call us Toll Free at 1-866-242-0905 or
Click here to begin your FREE Case Review
Due to recent medical alerts issued on Trasylol, medical experts are searching for alternative treatments and drugs that do not cause the potentially life-threatening complications such as heart attack, stroke, and kidney failure in patients who undergo coronary arterial bypass grafts and other major heart surgeries. This dangerous drug has already caused nearly 10,000 people to suffer from such extensive kidney failure to resort to dialysis, a painful and debilitating procedure that mechanically filters impurities from the blood.
There are currently two drugs that offer the same coagulating effects of Trayslol without serious side effects. Aminocaroic acid and tranexamic acid should deliver the same benefits of Trayslol without causing the same side effects. Doctors and scientists agree that these two generic pharmaceuticals would prevent an additional 11,000 kidney failures, save $1 billion dollars in healthcare expenditures, and have the added benefit of reducing drug costs around the world by at least $250 million.
Unfortunately, Bayer Pharmaceuticals refuses to acknowledge the claims that their drug caused any significant harm. They believe that the testing method used by the experts at the New England Journal of Medicine was improperly conducted, and that these results are inconsistent with findings compiled over the previous 13 years.
Many people who need coronary arterial bypass surgery are unaware that the drugs used to save their lives may eventually cause them more harm than good. Although the recent study that revealed the flaws in Trayslol was published in January 2006, many people who took the drug in years past could be at risk. If you or a loved one took Trayslol and suffered because of it, you could be entitled to compensation for your condition. Contact a knowledgeable defective drug attorney, and get started on your case today.
